0001209191-20-049921.txt : 20200910
0001209191-20-049921.hdr.sgml : 20200910
20200910090420
ACCESSION NUMBER: 0001209191-20-049921
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200909
FILED AS OF DATE: 20200910
DATE AS OF CHANGE: 20200910
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Daniell Richard
CENTRAL INDEX KEY: 0001726096
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16174
FILM NUMBER: 201167862
MAIL ADDRESS:
STREET 1: 5 BASEL STREET, PO BOX 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 4951033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD
CENTRAL INDEX KEY: 0000818686
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 BAZEL ST
STREET 2: P O B 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 49131
BUSINESS PHONE: 9729267267
MAIL ADDRESS:
STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED
STREET 2: 5 BAZEL ST PO B 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 49131
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-09-09
0
0000818686
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA
0001726096
Daniell Richard
C/O TEVA PHARMACEUTICAL INDUSTRIES LTD.
5 BASEL STREET
PETACH TIKVA
L3
4951033
ISRAEL
0
1
0
0
Exec. VP, European Commercial
Ordinary Shares
2020-09-09
4
M
0
698
A
11098
D
Ordinary Shares
2020-09-09
4
S
0
333
8.9844
D
10765
D
Restricted Share Units
2020-09-09
4
M
0
698
0.00
D
Ordinary Shares
698
0
D
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.9800 to $8.9850, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
Restricted share units were granted on September 9, 2016, with 696 vesting on each of September 9, 2018 and September 9, 2019 and 698 vesting on September 9, 2020.
/s/ Dov Bergwerk as attorney-in-fact for Richard Daniell
2020-09-10